socalTechnews
Log in | Join | Subscribe

Home
Mobile
News and Events
  • Headlines
  • Events
  • Interviews
  • Jobs
  • Directory
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
    • About
  • Membership
  • About
  • Contact Us
    		•

    Search News
    Monday, June 23, 2008

    EyeCyte Gets Funding
    San Diego-based EyeCyte, a firm developing products for the treatment of retinal disease, said Monday that it has raised a Series A funding round from Pfizer. The deal was worth $3M. EyeCyte said that its technology is based on research from The Scripps Research Institute in La Jolla. The firm is developing treatments for retinal diseases, including diabetic retinopathy, retinopathy of prematurity, retinal vascular occlusive disease, age-related macular degeneration (AMD) and retinitis pigmentosa.
    posted on Monday, June 23, 2008 (Link to more information)

    Related companies:
    Eyecyte

    Related stories:
    > Sambazon Gets Funding For Acai Beverages
    > Verari Garners $18M In Q4
    > OGPlanet Scores New Funding
    > Verimatrix Raises Series C Funding Round
    > Sendio Announces $4M in Funding

    RSS subscri be via emailEmail Twitter


    Previous news:

     Tuesday, January 6, 2009
    Monday, January 5, 2009
    Friday, January 2, 2009
    Wednesday, December 31, 2008
    Tuesday, December 30, 2008